erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Odland BA et al. Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe). 1999 Diagn. Microbiol. Infect. Dis. pmid:10459483
Luna VA et al. A variety of gram-positive bacteria carry mobile mef genes. 1999 J. Antimicrob. Chemother. pmid:10459806
Arpin C et al. Emergence of mefA and mefE genes in beta-haemolytic streptococci and pneumococci in France. 1999 J. Antimicrob. Chemother. pmid:10459823
Ando M et al. A new look at hypersensitivity pneumonitis. 1999 Curr Opin Pulm Med pmid:10461534
Cerbo M and Vecchione R [L-forms and pigment production in "Pseudomonas aeruginosa" (author's transl)]. 1978 May-Jun Ann Sclavo pmid:104666
Manners BT et al. An investigation of antibiotic resistance of Staphylococcus aureus in general practice. 1976 Practitioner pmid:1046672
Di Lorenzo C et al. Effect of sequential erythromycin and octreotide on antroduodenal manometry. 1999 J. Pediatr. Gastroenterol. Nutr. pmid:10467994
Huovinen P Causes, diagnosis and treatment of pharyngitis. 1999 Jun-Jul Compr Ther pmid:10470516
De Azavedo JC et al. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. 1999 Antimicrob. Agents Chemother. pmid:10471555
Cross NA et al. Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method. 1999 Antimicrob. Agents Chemother. pmid:10471587
Nawaz MS et al. Biochemical and molecular characterization of erthromycin-resistant avian Staphylococcus spp. isolated from chickens. 1999 Poult. Sci. pmid:10472846
Sofer D et al. 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. 1999 Sep-Oct Chemotherapy pmid:10473921
Mikamo H et al. Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis. 1999 Sep-Oct Chemotherapy pmid:10473928
Sturm A et al. Prokinetics in patients with gastroparesis: a systematic analysis. 1999 Sep-Oct Digestion pmid:10473966
Syphilis: CDC recommended treatment schedules 1976. 1976 Prim. Care pmid:1047450
Mikasa K et al. [Clinical application of the new action of macrolide preparations to respiratory diseases]. 1999 Nippon Naika Gakkai Zasshi pmid:10475020
Rizzo G et al. [Behavior of Vibrio cholerae strains of the biotype El Tor isolated in Apulia in 1973, in relation to various antibiotics and chemotherapeutics]. 1975 May-Jun Ann Sclavo pmid:1047628
Madinier IM et al. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans. 1999 J. Periodontol. pmid:10476896
Gabriëls M et al. Densitometric thin layer chromatographic analysis of tretinoin and erythromycin in lotions for topical use in acne treatment. 1999 Eur J Pharm Biopharm pmid:10477329
Howard KB et al. Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. 1999 Am J Health Syst Pharm pmid:10478989
Wilson DJ et al. Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. 1999 J. Dairy Sci. pmid:10480091
Cizman M et al. Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. 1999 Eur. J. Clin. Microbiol. Infect. Dis. pmid:10482034
Sarisuta N et al. Physico-chemical characterization of interactions between erythromycin and various film polymers. 1999 Int J Pharm pmid:10486428
Gómez-Lus R et al. Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens. 1999 J. Clin. Microbiol. pmid:10488213
Wieckiewicz JA Relationship between resistance to metallic ions and production of beta-lactamase in strains of Staphylococcus epidermidis. 1976 J Hyg Epidemiol Microbiol Immunol pmid:1048968
Kirsten D and Meister W [Present possibilities of antibiotic therapy in chronic non-specific respiratory diseases (author's transl)]. 1976 Z Erkr Atmungsorgane pmid:1049185
Moore PA Dental therapeutic indications for the newer long-acting macrolide antibiotics. 1999 J Am Dent Assoc pmid:10492541
Cash P et al. A proteomic analysis of erythromycin resistance in Streptococcus pneumoniae. 1999 Electrophoresis pmid:10493130
Gibson EM et al. Transfer of plasmid-mediated antibiotic resistance from streptococci to lactobacilli. 1979 J. Bacteriol. pmid:104973
Azuma A and Kudoh S [Diffuse panbronchiolitis: DPB]. 1999 Nippon Rinsho pmid:10497417
Zgoulli S et al. Microencapsulation of erythromycin and clarithromycin using a spray-drying technique. 1999 Sep-Oct J Microencapsul pmid:10499837
Moreno M et al. Clinical management of tacrolimus drug interactions in renal transplant patients. 1999 Transplant. Proc. pmid:10500564
Widdowson CA and Klugman KP Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. 1999 Semin Respir Infect pmid:10501313
Rosendal K et al. Staphylococcus aureus strains isolated in Danish hospitals from January 1st, 1966, to December 31st, 1974. 1976 Acta Pathol Microbiol Scand B pmid:1050144
Miossec-Bartoli C et al. The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells. 1999 Antimicrob. Agents Chemother. pmid:10508024
Oster P et al. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. 1999 Antimicrob. Agents Chemother. pmid:10508033
Khan SA et al. Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus spp. by multiplex-PCR. 1999 Mol. Cell. Probes pmid:10508560
Ahmad M et al. Disposition kinetics of erythromycin in normal and experimentally-induced febrile rabbits. 1999 Apr-Jun Eur J Drug Metab Pharmacokinet pmid:10510739
McMullin ST et al. Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. 1999 Arch. Intern. Med. pmid:10510994
Kinirons MT et al. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. 1999 Clin. Pharmacol. Ther. pmid:10511057
Ball SE et al. Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4. 1999 Clin. Pharmacol. Ther. pmid:10511065
Chantarotorn S et al. Diffuse panbronchiolitis, the first case reports in Thailand. 1999 J Med Assoc Thai pmid:10511794
Yoshida H and Furuta T [Tissue penetration properties of macrolide antibiotics--comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats]. 1999 Jpn J Antibiot pmid:10516929
De Winter BY et al. Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. 1999 Gut pmid:10517907
Xue Q et al. A multiplasmid approach to preparing large libraries of polyketides. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10518520
Sheu BS et al. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer. 1999 Jul-Aug Hepatogastroenterology pmid:10521999
Cocito C and Di Giambattista M The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits. 1978 Mol. Gen. Genet. pmid:105240
Shortridge VD et al. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. 1999 Clin. Infect. Dis. pmid:10524961
Yoh M et al. Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. 1999 Can. J. Microbiol. pmid:10526400
Sato A et al. Effects of organic anions and vinblastine on biliary excretion of erythromycin in rats. 1999 Pharmacology pmid:10529657